Disorder-dissociated effects of fluoxetine on brain function of working memory in attention deficit hyperactivity disorder and autism spectrum disorder

Psychological Medicine

Volumn 45, Issue 6, 2015, Pages 1195-1205

  Chantiluke, K ^a   Barrett, N ^b   Giampietro, V ^a   Brammer, M ^b   Simmons, A ^a,b   Rubia, K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

ADHD; ASD; fMRI; serotonin; working memory

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CHILD; CINGULATE GYRUS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL; SHORT TERM MEMORY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISM SPECTRUM DISORDER; CHILD; DOUBLE-BLIND METHOD; FLUOXETINE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; PREFRONTAL CORTEX; SEROTONIN UPTAKE INHIBITORS;

EID: 84925303507     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714002232     Document Type: Article

References (61)

1. Allen PP, Cleare AJ, Lee F, Fusar-Poli P, Tunstall N, Fu CH, Brammer MJ, McGuire PK (2006). Effect of acute tryptophan depletion on pre-frontal engagement. Psychopharmacology 187, 486-497.
2. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Publishing, Washington, DC.
3. Baddeley A (1996). The fractionation of working memory. Proceedings of the National Academy of Sciences USA 93, 13468-13472.
4. Baddeley A (2003). Working memory: looking back and looking forward. Nature Reviews Neuroscience 4, 829-839.
5. Barrickman L, Noyes R, Kuperman S, Schumacher E, Verda M (1991). Treatment of ADHD with fluoxetine: a preliminary trial. Journal of the American Academy of Child and Adolescent Psychiatry 30, 762-767.
6. Brammer MJ, Bullmore ET, Simmons A, Williams SCR, Grasby PM, Howard RJ, Woodruff PW, Rabe-Hesketh S (1997). Generic brain activation mapping in functional magnetic resonance imaging: a nonparametric approach. Magnetic Resonance Imaging 15, 763-770.
7. Bridgett DJ, Walker ME (2006). Intellectual functioning in adults with ADHD: a meta-analytic examination of full scale IQ differences between adults with and without ADHD. Psychological Assessment 18, 1-14.
8. Buchsbaum MS, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S (2001). Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. International Journal of Neuropsychopharmacology 4, 119-125.
9. Bullmore E, Brammer M, Rabe-Hesketh S, Curtis V, Morris R, Williams S, Sharma T, McGuire P (1999a). Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI. Human Brain Mapping 7, 38-48.
10. Bullmore E, Long C, Suckling J, Fadili J, Calvert G, Zelaya F, Carpenter TA, Brammer M (2001). Colored noise and computational inference in neurophysiological (fMRI) time series analysis: resampling methods in time and wavelet domains. Human Brain Mapping 12, 61-78.
11. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999b). Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Transactions on Medical Imaging 18, 32-42.
12. Carrasco M, Volkmar FR, Bloch MH (2012). Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias. Pediatrics 129, 1301-1310.
13. Christakou A, Murphy CM, Chantiluke K, Cubillo AI, Smith AB, Giampietro V, Daly E, Ecker C, Robertson D, Murphy DG, Rubia K (2013). Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Molecular Psychiatry 18, 236-244.
14. Conners CK, Sitarenios G, Parker JDA, Epstein JN (1998). The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. Journal of Abnormal Child Psychology 26, 257-268.
15. Conway AR, Kane MJ, Engle RW (2003). Working memory capacity and its relation to general intelligence. Trends in Cognitive Sciences 7, 547-552.
16. Corbett BA, Constantine LJ, Hendren R, Rocke D, Ozonoff S (2009). Examining executive functioning in children with autism spectrum disorder, attention deficit hyperactivity disorder and typical development. Psychiatry Research 166, 210-222.
17. Cubillo A, Smith A, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K (2014). Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory. Psychological Medicine 44, 633-646.
18. Cui J, Gao D, Chen Y, Zou X, Wang Y (2010). Working memory in early-school-age children with Asperger's syndrome. Journal of Autism and Developmental Disorders 40, 958-967.
19. Dalley JW, Roiser JP (2012). Dopamine, serotonin and impulsivity. Neuroscience 215, 42-58.
20. Dennis M, Francis DJ, Cirino PT, Schachar R, Barnes MA, Fletcher JM (2009). Why IQ is not a covariate in cognitive studies of neurodevelopmental disorders. Journal of the International Neuropsychological Society 15, 331-343.
21. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283, 397-401.
22. Gammon GD, Brown TE (1993). Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. Journal of Child and Adolescent Psychopharmacology 3, 1-10.
23. Ginestet CE, Simmons A (2011). Statistical parametric network analysis of functional connectivity dynamics during a working memory task. NeuroImage 55, 688-704.
24. Gizer IR, Ficks C, Waldman ID (2009). Candidate gene studies of ADHD: a meta-analytic review. Human Genetics 126, 51-90.
25. Goldberg D, Murray R (eds) (2002). The Maudsley Handbook of Practical Psychiatry. Oxford Medical Publications: Oxford.
26. Goodman R, Scott S (1999). Comparing the Strengths and Difficulties Questionnaire and the Child Behavior Checklist: is small beautiful? Journal of Abnormal Child Psychology 27, 17-24.
27. Hahn A, Wadsak W, Windischberger C, Baldinger P, Höflich AS, Losak J, Nics L, Philippe C, Kranz GS, Kraus C, Mitterhauser M, Karanikas G, Kasper S, Lanzenberger R (2012). Differential modulation of the default mode network via serotonin-1A receptors. Proceedings of the National Academy of Sciences USA 109, 2619-2624.
28. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/ hyperactivity disorder: exploring task-specific, stimulant medication, and age effects. Journal of the American Medical Association Psychiatry 70, 185-198.
29. Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C (2012). A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. American Journal of Psychiatry 169, 292-299.
30. Hranilovic D, Bujas-Petkovic Z, Vragovic R, Vuk T, Hock K, Jernej B (2007). Hyperserotonemia in adults with autistic disorder. Journal of Autism and Developmental Disorders 37, 1934-1940.
31. Kasper LJ, Alderson RM, Hudec KL (2012). Moderators of working memory deficits in children with attention-deficit/ hyperactivity disorder (ADHD): a meta-analytic review. Clinical Psychology Review 32, 605-617.
32. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L, Hirtz D, Wagner A, Ritz L, Network SP (2009). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Archives of General Psychiatry 66, 583-590.
33. Kobel M, Bechtel N, Weber P, Specht K, Klarhofer M, Scheffler K, Opwis K, Penner IK (2009). Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder. European Journal of Paediatric Neurology 13, 516-523.
34. Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA (2005). Functional connectivity in an fMRI working memory task in high-functioning autism. NeuroImage 24, 810-821.
35. Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, Pickles A, Rutter M (2000). The Autism Diagnostic Observation Schedule Generic: a standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders 30, 205-223.
36. Lord C, Rutter M, Couteur A (1994). Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders 24, 659-685.
37. McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Hellemann GSugar CA (2009). A candidate gene analysis of methylphenidate response in attentiondeficit/ hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 48, 1155-1164.
38. Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S, Erlandsson K, Eersels J, Kerwin R, Ell P, Travis M (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. American Journal of Psychiatry 163, 934-936.
39. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, Tsuchiya KJ, Sugihara G, Iwata Y, Suzuki K, Matsuzaki H, Suda S, Sugiyama T, Takei N, Mori N (2010). Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Archives of General Psychiatry 67, 59-68.
40. Nishizawa S, Benkelfat C, Young S, Leyton M, Mzengeza S, De Montigny C, Blier P, Diksic M (1997). Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences USA 94, 5308-5313.
41. Northoff G, Qin P, Nakao T (2010). Rest-stimulus interaction in the brain: a review. Trends in Neurosciences 33, 277-284.
42. Oades RD (2007). Role of the serotonin system in ADHD: treatment implications. Expert Review of Neurotherapeutics 7, 1357-1374.
43. Oades RD (2008). Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Progress in Brain Research 172, 543-565.
44. Oades RD (2010). The role of serotonin in attention-deficit hyperactivity disorder (ADHD). Handbook of Behavioral Neuroscience 21, 565-584.
45. Oldfield RC (1971). The assessment andanalysis ofhandedness: the Edinburgh inventory. Neuropsychologia 9, 97-113.
46. Quintana H, Butterbaugh GJ, PurnellW, Layman AK (2007). Fluoxetine monotherapy in attention-deficit/hyperactivity disorder and comorbid non-bipolar mood disorders in children and adolescents. Child Psychiatry and Human Development 37, 241-253.
47. Rommelse NNJ, Geurts HM, Franke B, Buitelaar JK, Hartman CA (2011). A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes. Neuroscience and Biobehavioral Reviews 35, 1363-1396.
48. Rose EJ, Simonotto E, Spencer EP, Ebmeier KP (2006). The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology 185, 339-347.
49. Rutter M, Bailey A, Lord C (2003). The Social Communication Questionnaire: Manual. Western Psychological Services: Los Angeles, CA.
50. Sonuga-Barke EJ, Kumsta R, Schlotz W, Lasky-Su J, Marco R, Miranda A, Mulas F, Oades RD, Banaschewski T, Mueller U (2011). A functional variant of the serotonin transporter gene SLC6A4 moderates impulsive choice in attention-deficit/hyperactivity disorder boys and siblings. Biological Psychiatry 70, 230-236.
51. Spivak B, Vered Y, Yoran-Hegesh R, Averbuch E, Mester R, Graf E, Weizman A (1999). Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta Psychiatrica Scandinavica 99, 300-304.
52. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers: New York.
53. Thirion B, Pinel P, Meriaux S, Roche A, Dehaene S, Poline JB (2007). Analysis of a large fMRI cohort: statistical and methodological issues for group analyses. NeuroImage 35, 105-120.
54. Wager TD, Smith EE (2003). Neuroimaging studies of working memory: a meta-analysis. Cognitive Affective and Behavioral Neuroscience 3, 255-274.
55. Wechsler D (1999). Wechsler Abbreviated Scale of Intelligence. The Psychological Corporation: San Antonio, TX.
56. Wechsler D (2004). Wechsler Intelligence Scale for Children, Fourth UK Edition. The Psychological Corporation: London.
57. West L, Brunssen SH, Waldrop J (2009). Review of the evidence for treatment of children with autism with selective serotonin reuptake inhibitors. Journal for Specialists in Pediatric Nursing 14, 183-191.
58. WHO (1994). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.
59. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF (2005). Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biological Psychiatry 57, 1336-1346.
60. Williams K, Wheeler DM, Silove N, Hazell P (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews. Issue 8, Art. No. CD004677.
61. Wong DT, Bymaster FP, Engleman EA (1995). Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sciences 57, 411-441.